title: Phenytoin desensitization in a child with symptomatic localization-related epilepsy.
abstract: We reported a child with refractory partial seizures successfully managed by clinical desensitization to phenytoin. The patient had ischemic brain lesions due to cardiopulmonary arrest at 39 weeks of corrected age. He had complex partial seizures refractory to several antiepileptic drugs since 4 years of age. At 8 years 1 month of age, phenytoin was first administered. Fever and maculopapular rashes appeared at 10 days after phenytoin initiation, and then the drug was discontinued. At 8 years 8 months of age, desensitization was attempted because of refractoriness of seizures to drugs other than phenytoin. Desensitization was started at 1mg daily, and then the dose was doubled every week. His seizures were controlled by 150mg/day of phenytoin in combination with primidone. No problems have been observed during desensitization.
authors.affiliation: Department of Pediatrics, Nagoya First Red Cross Hospital, Nagoya, Aichi, Japan. itomis@dsl.sun-inet.or.jp
authors.forename: Seiko
authors.initials: S
authors.lastname: Itomi
authors.forename: Akihisa
authors.initials: A
authors.lastname: Okumura
authors.forename: Taketo
authors.initials: T
authors.lastname: Ikuta
authors.forename: Tamiko
authors.initials: T
authors.lastname: Negoro
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Watanabe
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D002648:Child; D004359:Drug Therapy, Combination; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010672:Phenytoin / Q000009:adverse effects*; D011324:Primidone / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin